IMPORTANT INFORMATION REGARDING WEIGHT LOSS INJECTIONS – PLEASE READ. Please don’t contact your GP just yet as they’re unable to help currently.

From 23 June, people living with obesity will be able to begin accessing tirzepatide (Mounjaro®) for weight loss purposes in primary care settings. This does not mean prescriptions will be provided immediately. It means primary care settings can begin discussions with patients about whether tirzepatide is the right option to improve their health through weight loss.

In Hampshire and the Isle of Wight around 1,000 people currently qualify for the medication based on national eligibility criteria – we are working to set up services quickly however this it will not be available locally until later this year (Autumn) – so please don’t contact your GP just yet as they’re unable to help currently. We will update this webpage when we have more information.